These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16094769)

  • 1. Teriparatide, osteoporosis, calcium, and vitamin D.
    Krege JH; Donley DW; Marcus R
    N Engl J Med; 2005 Aug; 353(6):634-5; author reply 634-5. PubMed ID: 16094769
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis, teriparatide, and dosing of calcium and vitamin D.
    Licata AA
    N Engl J Med; 2005 May; 352(18):1930-1. PubMed ID: 15872215
    [No Abstract]   [Full Text] [Related]  

  • 3. Teriparatide, osteoporosis, calcium, and vitamin D.
    Vieth R; Cole DE
    N Engl J Med; 2005 Aug; 353(6):634-5; author reply 634-5. PubMed ID: 16093478
    [No Abstract]   [Full Text] [Related]  

  • 4. Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.
    Sugimoto T; Shiraki M; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Kuroda T; Nakamura T
    Curr Med Res Opin; 2013 Mar; 29(3):195-203. PubMed ID: 23259702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment.
    Monegal A; Peris P; Alsina M; Colmenero J; Guañabens N
    Osteoporos Int; 2016 Aug; 27(8):2631-4. PubMed ID: 27010647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in vitamin D metabolites during teriparatide treatment.
    Cosman F; Dawson-Hughes B; Wan X; Krege JH
    Bone; 2012 Jun; 50(6):1368-71. PubMed ID: 22426307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporosis in elderly].
    Lüttje D
    Dtsch Med Wochenschr; 2015 Apr; 140(7):473-6. PubMed ID: 25826028
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
    Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teriparatide: new indication. During corticosteroid therapy: no fewer clinical fractures. Unnecessarily inconvenient.
    Prescrire Int; 2009 Aug; 18(102):159. PubMed ID: 19743573
    [No Abstract]   [Full Text] [Related]  

  • 11. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
    Miller PD; Schwartz EN; Chen P; Misurski DA; Krege JH
    Osteoporos Int; 2007 Jan; 18(1):59-68. PubMed ID: 17013567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating osteoporosis with teriparatide: many unknowns?
    Shukla VK
    Issues Emerg Health Technol; 2003 Nov; (51):1-4. PubMed ID: 14610756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.
    Yamamoto T; Tsujimoto M; Sowa H
    Clin Interv Aging; 2015; 10():1101-9. PubMed ID: 26185429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonates first-line pharmacological treatment].
    Wallander M; Ljunggren Ö; Lorentzon M
    Lakartidningen; 2016 Nov; 113():. PubMed ID: 27824394
    [No Abstract]   [Full Text] [Related]  

  • 16. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of drugs for osteoporosis on cardiovascular diseases and effect of cardio vascular drugs on osteoporosis].
    Laroche M; Degboe Y; Blain H; Breuil V; Chapurlat R; Cortet B; Sutter B;
    Presse Med; 2017 Mar; 46(2 Pt 1):159-164. PubMed ID: 28040349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis].
    Uelbelhart B; Rizzoli R
    Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.
    Prescrire Int; 2005 Feb; 14(75):5-9. PubMed ID: 15747448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of osteoanabolic therapy: a decade of experience.
    Cipriani C; Irani D; Bilezikian JP
    J Bone Miner Res; 2012 Dec; 27(12):2419-28. PubMed ID: 23165426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.